Stephens downgraded Accolade (ACCD) to Equal Weight from Overweight with a price target of $7.03, down from $8, after the company released its fiscal Q3 results this morning via 10-Q with no call, as expected, following the announcement earlier this week of a definitive agreement for Transcarent to purchase Accolade for $7.03 per share. The firm is downgrading shares given that they are trading within 3% of deal price and it expects the deal to close without issue at the announced price, the analyst tells investors.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACCD:
- Options Volatility and Implied Earnings Moves Today, January 09, 2025
- Accolade downgraded to Market Perform from Outperform at Raymond James
- Accolade downgraded to Hold from Buy at Stifel
- Accolade downgraded to Hold from Buy at Needham
- Exxon and Shell cautious on Q4, Flutter cuts guidance: Morning Buzz